(Relief, or the Company), a biopharmaceutical company committed to delivering innovative treatment options for select specialty, unmet and rare diseases, today announced that the European Patent ...
The European Union starts an investigation January 30 into its ailing automotive manufacturers as the industry seeks relief from the existential threat of tightening CO2 emissions rules and their ...
Relief Therapeutics Announces European Patent Office Decision to Grant Patent for RLF-TD011 11.02.2025 / 07:00 CET/CEST Relief Therapeutics Announces European Patent Office Decision to Grant ...